Anti-proliferative therapy for HIV cure: a compound interest approach
Abstract In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integra...
Guardado en:
Autores principales: | Daniel B. Reeves, Elizabeth R. Duke, Sean M. Hughes, Martin Prlic, Florian Hladik, Joshua T. Schiffer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bd56a0f58ac4f5799ab988ad7daaffa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
por: Daniel B. Reeves, et al.
Publicado: (2018) -
Can a topical microbicide prevent rectal HIV transmission?
por: Florian Hladik, et al.
Publicado: (2008) -
Nonhuman primate models for HIV cure research.
por: Cristian Apetrei, et al.
Publicado: (2012) -
Editorial: Novel Insights Into a Functional HIV Cure
por: Luca Sardo, et al.
Publicado: (2021) -
Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Ani Korhonen, et al.
Publicado: (2021)